The immunoengineering field is transforming cancer, autoimmunity, regeneration, and transplantation treatments by combining the diverse and complex fields of engineering and immunology. This symposium will highlight some of the latest advances in immunoengineering with a focus on translational aspects of the field. It is also a celebration of Johns Hopkins Translational ImmunoEngineering Center renewal and its accomplishments.

Keynote Speakers
Michel Sadelain, MD
Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy

Robert Seder, MD
Chief, Cellular Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH